SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.65-0.9%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Perry who wrote (2072)5/6/1998 4:25:00 AM
From: Z Analyzer  Read Replies (2) of 9523
 
<<With all due respect I'll stick with my brokers analysis that clearly points out that
valuations for PFE is not excessive based on the P/E premium. However, like I said
we'll know in a few months who is right.>> Wonder if you could share that analysis with us and tell us which firm? Actually it will be a few years before anybody knows who is right. In several months, someone may just think they are right. And my numbers used $10 bil in sales. To put that in perspective, the worlds largest brewer, Anhauser -Busch is in that ballpark. What I don't understand is why analysts generally continue to use such low numbers for annual sales.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext